|
|
|
Volumn 16, Issue 5, 2002, Pages
|
|
Controversies in early-stage Hodgkin's disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HODGKIN DISEASE;
HUMAN;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
HODGKIN DISEASE;
HUMANS;
NEOPLASM STAGING;
PROGNOSIS;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0036560242
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (42)
|
